Patent ID: 11957707
Assignee: SYNEDGEN, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method for treating or preventing Acute Respiratory Distress Syndrome (ARDS) in a subject, the method comprising administering to the subject by inhalation an effective amount of a composition comprising a neutral osmol agent and a poly (acetyl, arginyl) glucosamine (PAAG) comprising the following formula (I):, wherein:
n is an integer between 20 and 6000; and
each R1 is independently selected for each occurrence from hydrogen, acetyl,, wherein at least 25% of R1 substituents are H, at least 1% of R1 substituents are acetyl, and at least 2% of R1 substituents are, wherein the osmolality of the composition is between 150-550 mOsmol/kg; and
wherein the neutral osmol agent is selected from the group consisting of glycerol, sorbitol, mannitol, xylitol, erythritol, and trehalose.